Anemia: Drug Therapy

Therapeutic target

Remediation of the anemia

Therapy recommendations

• Aplastic anemia: see below for the disease of the same name.
• Iron deficiency anemia: see below of the disease of the same name.
• Hemolytic anemia: see below of the disease of the same name.
• Megaloblastic anemia: see below of the disease of the same name.
• Renal anemia: see below of the disease of the same name.
• Tumor anemia (tumor therapy-associated anemia) → erythropoietic administration.
• Treatment of underlying diseases:
  • Erythropoietin administration in renal anemia (kidney-related anemia) and juvenile idiopathic arthritis (joint inflammation).
  • Thyroid hormone replacement in hypothyroidism (hypothyroidism).
• Transfusion of erythrocytes (red blood cells).
  • Hemoglobin (Hb) < 6 g/dl, usually erythrocyte concentrate (EC).
  • Hemoglobin (hb) < 4.5-5.0 g/dl (< 2.8-3.1 mmol/l): absolute transfusion indication.